FluidAI Medical announces $15M in Series A funding for AI-driven postoperative monitor at HLTH 2023

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

FluidAI Medical, a pioneer in leveraging artificial intelligence (AI) for postoperative patient monitoring, recently announced that it has raised $15 million in Series A funding. The investment will allow FluidAI to develop deeper medical record integration, expand into existing and new global markets, grow its dynamic team, and introduce novel AI-driven solutions catering to a broader range of postoperative complications.

Fluid AI is an OBIO® member and an alumnus of all OBIO® programs.

Arsheen Kaur
Previous

AI at the bedside: First-ever Extubation Decision Support Product approved in Canada
Next

Conavi Medical announces closing of financing to bolster novel intravascular imaging technology